https://www.kaicet.org/community/board/ 2026-07-14T00:18:00+00:00 https://www.kaicet.org/community/board/2026_il13ra2-car-t-immunotherapy-forrecurrent-malignant-gliomas-phase-1-experience-and-future-perspective_ho-shin-gwak/ 2026-07-14T00:18:00+00:00 https://www.kaicet.org/community/board/2026_3-1-lunch-to-learning_unlocking-the-present-and-future-of-clinimacs-prodigy_miltenyi-biotec-korea/ 2026-07-14T00:14:02+00:00 https://www.kaicet.org/community/board/in-vivo-crispr-engineering-to-generate-trac-targeted-car-t-cells/ 2026-07-14T00:13:38+00:00 https://www.kaicet.org/community/board/2026_3-3-a-scalable-framework-for-crispr-off-targeted-deep-sequencing_integrated-dna-technologies-usa/ 2026-07-14T00:11:41+00:00 https://www.kaicet.org/community/board/2026_1-3-non-viral-car-nk-platforms-for-broad-therapeutic-application-in-cancer-and-beyond_mihue-jang/ 2026-07-14T00:08:25+00:00 https://www.kaicet.org/community/board/2026_3-2-%ec%84%b8%ed%8f%ac-%ea%b0%84-%ea%b2%b0%ed%95%a9%ea%b3%bc-%ec%83%81%ed%98%b8%ec%9e%91%ec%9a%a9%ec%9d%84-%ec%9d%b4%ed%95%b4%ed%95%98%eb%8a%94-%ed%95%b5%ec%8b%ac-cell-avidity_rhino-bio-inc/ 2026-07-14T00:08:08+00:00 https://www.kaicet.org/community/board/2026-2-3_mrna-therapeutics-for-in-situ-cancer-immunotherapy_ji-ho-park/ 2026-07-14T00:02:32+00:00